Atlas Trials

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Clinical trial NCT04495088 · RECRUITING

Trial details

NCT number
NCT04495088
Sponsor
Ralf Hofheinz
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2020-09-30
Primary completion
2030-08-01
Enrollment
550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.